CONCANAMYCIN A
CONCANAMYCIN A Basic information
- Product Name:
- CONCANAMYCIN A
- Synonyms:
-
- CONCANAMYCIN A
- CONCANAMYCIN A, STREPTOMYCES SP
- concanamycin A from streptomyces species
- A661-I
- Antibiotic A661I
- Antibiotic S-45A
- S-45A
- (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[[4-O-(Aminocarbonyl)-2,6-dideoxy-β-D-arabino-hexopyranosyl]oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propenyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyloxacyclooctadeca-3,5,13,15-tetraen-2-one
- CAS:
- 80890-47-7
- MF:
- C46H75NO14
- MW:
- 866.09
- EINECS:
- 620-709-4
- Mol File:
- 80890-47-7.mol
CONCANAMYCIN A Chemical Properties
- Melting point:
- 179-180℃ (dichloromethane ethanol )
- Boiling point:
- 966.4±65.0 °C(Predicted)
- Density
- 1.20±0.1 g/cm3(Predicted)
- storage temp.
- −20°C
- solubility
- Soluble in DMSO
- pka
- 12.46±0.70(Predicted)
- form
- Lyophilized solid
- color
- White
- BRN
- 3560277
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
- InChIKey
- DJZCTUVALDDONK-NZJBBTFCNA-N
Safety Information
- Hazard Codes
- T+
- Risk Statements
- 26/27/28-36
- Safety Statements
- 26-36/37/39-45
- RIDADR
- UN 3462 6.1/PG 2
- WGK Germany
- 3
- RTECS
- CB9732000
- F
- 10-21
- HazardClass
- 6.1(b)
- PackingGroup
- III
- HS Code
- 2941900000
MSDS
- Language:English Provider:SigmaAldrich
CONCANAMYCIN A Usage And Synthesis
Description
Concanamycin A (80890-47-7) is a potent and specific inhibitor of the vacuolar (V-type) H+-ATPase which can induce apoptotic cell death in various cell lines.1,2?Inhibits cell surface expression of virus envelope glycoproteins.3?Dramatically increases the rate of extracellular vesicle release from a variety of cell types.4?Inhibits autophagy by blocking lysosomal acidification.5
Uses
Concanamycin A is the major analogue of the concanamycin complex produced by Streptomyces sp.. It has been shown to act as a potent and specific vacuolar-ATPase inhibitor. Concanamycin A inhibits the acidification of organelles and blocks cell surface expression of viral envelope glycoproteins without affecting their synthesis. It also interferes with intracellular protein trafficking and inhibits perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. Concanamycins are structurally related to the bafilomycins.
Uses
Concanamycin A has been used:
- as a lysosomal inhibitor in young and old fibroblasts
- as a vacuolar-type H+-ATPase inhibitor in presynaptic vesicles
- as a lysosomal acidification blocker in HepG2 hepatocytes cells
Definition
ChEBI: A concanamycin in which the lactone ring contains 4 double bonds and is substituted by 4 methyl groups, 2 hydroxy groups, 2 methoxy groups and an ethyl group.
General Description
Chemical structure: macrolide
Biological Activity
Specific inhibitor of V-type (vacuolar) H + -ATPase that displays > 2000-fold selectivity over other H + -ATPases (IC 50 values are 9.2, > 20000, > 20000 and > 20000 nM for yeast V-type, F-type, P-type H + -ATPases and porcine P-type Na + ,K + -ATPase respectively). Blocks cell surface expression of virus envelope glycoproteins without affecting synthesis and exhibits cytotoxicity in several cell lines.
Biochem/physiol Actions
Concanamycin A (ConA) inhibits acidification of organelles and perforin-mediated cytotoxicity. It is a vacuolar-type v-ATPase inhibitor. ConA possesses antiprotozoal and antineoplastic properties. It mediates inhibition of the negative factor (Nef) protein of the human immunodeficiency virus.
storage
Store at -20°C
References
[1] NISHIHARA T. Specific Inhibitors of Vacuolar Type H+-ATPases Induce Apoptotic Cell Death[J]. Biochemical and biophysical research communications, 1995, 212 1: Pages 255-262. DOI:10.1006/bbrc.1995.1964
[2] JANGJA HONG. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.[J]. Journal of Pharmacology and Experimental Therapeutics, 2006, 319 2: 672-681. DOI:10.1124/jpet.106.109280
[3] M MUROI. Folimycin (concanamycin A), a specific inhibitor of V-ATPase, blocks intracellular translocation of the glycoprotein of vesicular stomatitis virus before arrival to the Golgi apparatus.[J]. Cell structure and function, 1993, 18 3: 139-149. DOI:10.1247/csf.18.139
[4] ANIL G CASHIKAR P I H. A cell-based assay for CD63-containing extracellular vesicles.[J]. ACS Applied Bio Materials, 2019: e0220007. DOI:10.1371/journal.pone.0220007
[5] SYLWIA GRADZKA. Inhibitor of apoptosis proteins are required for effective fusion of autophagosomes with lysosomes.[J]. Cell Death & Disease, 2018: 529. DOI:10.1038/s41419-018-0508-y
CONCANAMYCIN ASupplier
- Tel
- 025-85560043 13675144456
- sean.lv@synzest.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 0731-85526065 13308475853
- ivy@hnhbsj.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
CONCANAMYCIN A(80890-47-7)Related Product Information
- BUTYL SORBATE
- 2,4-DECADIEN-1-OL
- 2,4-NONADIEN-1-OL
- ETHYL SORBATE
- ISODECYL ACRYLATE
- (E,E)-2,4-Dodecadienal
- CONCANAMYCIN A
- trans,trans-2,4-undecadienal
- CONCANAMYCIN A,CONCANAMYCIN A, STREPTOMYCES SP
- 2-methoxyethyl carbamate
- 2,4-DECADIENOIC ACID METHYL ESTER
- 2,4-UNDECADIEN-1-OL
- viranamycin B
- concanamycin G
- concanamycin E
- concanamycin D
- Ethyl-2,4-decadienoate
- hedonal